Baricitinib

被引：4

作者：

不详

机构：

来源：

AUSTRALIAN PRESCRIBER | 2019年 / 42卷 / 01期

关键词：

RHEUMATOID-ARTHRITIS; INADEQUATE RESPONSE;

D O I：

10.18773/austprescr.2018.070

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：34 / 35

页数：2

共 7 条

[1] Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study [J].

Dougados, Maxime ;

van der Heijde, Desiree ;

Chen, Ying-Chou ;

Greenwald, Maria ;

Drescher, Edit ;

Liu, Jiajun ;

Beattie, Scott ;

Witt, Sarah ;

de la Torre, Inmaculada ;

Gaich, Carol ;

Rooney, Terence ;

Schlichting, Douglas ;

de Bono, Stephanie ;

Emery, Paul .

ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (01) :88-95

[2] Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment [J].

Fleischmann, Roy ;

Schiff, Michael ;

van der Heijde, Desiree ;

Ramos-Remus, Cesar ;

Spindler, Alberto ;

Stanislav, Marina ;

Zerbini, Cristiano A. F. ;

Gurbuz, Sirel ;

Dickson, Christina ;

de Bono, Stephanie ;

Schlichting, Douglas ;

Beattie, Scott ;

Kuo, Wen-Ling ;

Rooney, Terence ;

Macias, William ;

Takeuchi, Tsutomu .

ARTHRITIS & RHEUMATOLOGY, 2017, 69 (03) :506-517

[3] Baricitinib in Patients with Refractory Rheumatoid Arthritis [J].

Genovese, Mark C. ;

Kremer, Joel ;

Zamani, Omid ;

Ludivico, Charles ;

Krogulec, Marek ;

Xie, Li ;

Beattie, Scott D. ;

Koch, Alisa E. ;

Cardillo, Tracy E. ;

Rooney, Terence P. ;

Macias, William L. ;

de Bono, Stephanie ;

Schlichting, Douglas E. ;

Smolen, Josef S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (13) :1243-1252

[4] Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate [J].

Keystone, Edward C. ;

Taylor, Peter C. ;

Drescher, Edit ;

Schlichting, Douglas E. ;

Beattie, Scott D. ;

Berclaz, Pierre-Yves ;

Lee, Chin H. ;

Fidelus-Gort, Rosanne K. ;

Luchi, Monica E. ;

Rooney, Terence P. ;

Macias, William L. ;

Genovese, Mark C. .

ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) :333-340

[5]

Kubler P., 2014, AUST PRESCR, V37, P154, DOI [10.18773/austprescr.2014.061, DOI 10.18773/AUSTPRESCR.2014.061]

[6] Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis [J].

Taylor, Peter C. ;

Keystone, Edward C. ;

van der Heijde, Desiree ;

Weinblatt, Michael E. ;

del Carmen Morales, Liliana ;

Reyes Gonzaga, Jaime ;

Yakushin, Sergey ;

Ishii, Taeko ;

Emoto, Kahaku ;

Beattie, Scott ;

Arora, Vipin ;

Gaich, Carol ;

Rooney, Terence ;

Schlichting, Douglas ;

Macias, William L. ;

de Bono, Stephanie ;

Tanaka, Yoshiya .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (07) :652-662

[7]

Walker J, 2014, AUST PRESCR, V37, P158

← 1 →